BUSINESS
Closing Bell: Sensex up 179 points, Nifty above 18,300; IndusInd, PowerGrid, Tata Motors top gainers
BUSINESS
US sales, brand deals to seal the fortune for Dr Reddy's in Q4
BUSINESS
Closing Bell: Indices close flat, Nifty near 18,250; ITC, SBI, Bajaj Finance worst hit
BUSINESS
One-time loss, weak operational performance drags UPL Q4 earnings below street expectations
BUSINESS
UPL shares trade marginally higher on hopes of robust Q4 earnings
BUSINESS
Closing Bell: Sensex gains 710 pts, Nifty settles above 18,250; Tata Motors, IndusInd Bank, Bajaj Finance shine
BUSINESS
Chemicals Q4 preview: A mixed bag, agri-input companies seen weak, specialty chemicals firms may grow
BUSINESS
Here's why it’s time to take note of small and mid-cap pharma stocks
BUSINESS
Closing Bell: Nifty above 18,000, Sensex gains 463 pts; all sectors in the green
BUSINESS
Why investors gave a thumbs down to Ipca Labs’ Unichem acquisition?
BUSINESS
Lupin shares bounce back 10.5% in one month; should investors jump on the bandwagon?
BUSINESS
Ipca Labs hits fresh 52-week low as Unichem acquisition spoils mood for second day
BUSINESS
Are pharma cos poised for a bull ride? Here's what analysts believe
BUSINESS
Ami Organics shares surge 4% on plans to acquire 55% in Baba Fine Chemicals
BUSINESS
Sun Pharma slips 3% on production halt at Mohali unit for corrective actions
BUSINESS
Sun Pharma pauses production at Mohali facility to implement US FDA corrective actions
BUSINESS
Midcap Magic | Ajanta Pharma favoured by analysts for long-term growth
BUSINESS
JP Morgan has downgraded 2 IT players; here is why
BUSINESS
ICICI Securities plummets 6% as Q4 net tanks 23% on higher cost of funds
BUSINESS
Hospital sector likely to firm up on higher occupancy, favourable base in Q4
BUSINESS
MFs sell Dr Reddy’s shares for three consecutive months; stock still gains 16% year-to-date
BUSINESS
Bernstein starts coverage on Delhivery with 'market-perform' rating, sees 11% upside
BUSINESS
Nuvama sees high risk of OAI classification as Lupin facility faces US FDA heat
BUSINESS
Highest risk, maximum reward in healthcare lies in diagnostics, says Incred PMS' Aditya Khemka
